查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1857951

經皮皮腎結石清除術市場按產品類型、手術類型、最終用戶、技術、應用和病患類型分類－2025-2032年全球預測

Percutaneous Nephrolithotomy Market by Product Type, Procedure Type, End User, Technology, Application, Patient Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，經皮皮腎結石清除市場規模將達到 370.7 億美元，複合年成長率為 8.24%。

關鍵市場統計數據
基準年 2024 196.6億美元
預計年份：2025年 212.7億美元
預測年份 2032 370.7億美元
複合年成長率 (%) 8.24%

經皮腎鏡取石術的權威概述，說明了當代臨床實踐、器械生態系統以及影響醫療服務的各種手術方法。

經皮腎鏡取石術是現代泌尿系統治療複雜及大型腎結石的基石。近年來，該手術已從最初的院內手術發展到如今多種入路方式，這些方式的特點在於不同的器械尺寸、能量模式和手術全期路徑。這項發展得益於器械工程、光學技術和能量輸送系統的同步進步，以及病患和支付方不斷變化的需求，他們更重視縮短住院時間、加速復原速度和確保手術安全性。

在此背景下，臨床團隊通常會考慮一套完整的產品和手術方案。核心手術設備包括腎臟鏡、碎石機以及各種配件，例如取石籃、擴張器、導管導引線和鞘套。手術方案涵蓋微型、迷你、標準和超迷你等多種類型，每種方案都根據結石負荷、腎臟解剖結構和患者合併症量身定做。最終用戶包括獨立門診手術中心、醫院附屬門診手術中心、私人醫院和公立醫院，可以選擇雷射、氣動和超音波等技術。應用通常區分腎結石和更廣泛的鹿角狀結石，成人和兒童患者群體也存在差異。總而言之，這些要素共同構成了現代臨床路徑及其背後的商業性生態系統。

技術小型化、能源多樣化和臨床實踐的演變如何重塑腎結石手術的臨床常規和商業策略

經經皮腎結石清除術的格局正在經歷多重變革，這些變革由技術、操作和以患者為中心的因素共同驅動。技術的微型化和內視鏡光學技術的進步使得微創手術方案更加多樣化，促使臨床醫生重新思考傳統的結石尺寸閾值和手術全期要求。同時，能量平台也在不斷多樣化。雷射系統隨著光纖設計和能量調製技術的改進而日益成熟；氣動和超音波方式對於某些成分的結石仍然十分重要；此外，混合式方法也正在湧現，以最佳化結石的碎裂和排放。

在營運方面，門診和早期復健模式正成為明顯的趨勢。隨著臨床醫生和管理人員採用既能縮短住院時間又不影響安全性的通訊協定，手術選擇和器械組合正在重新評估。供應鏈的韌性和成本效益也變得日益重要，促使醫院和門診中心重新協商服務契約，權衡一次性使用和重複使用之間的利弊，並探索戰略採購方案。最後，監管機構的嚴格審查以及支付方對結果和價值的關注，促使製造商提供可靠的臨床證據，並支持旨在促進新手術和器械安全應用的培訓計畫。

評估美國關稅政策變化對2025年醫療設備採購、製造策略和醫療服務提供者採購行為的營運和採購影響

2025年影響關稅和貿易的政策決定將對經皮取石術供應鏈產生重大影響。依賴跨國零件採購的製造商正面臨到岸成本上升的困境，促使採購團隊重新評估其資本設備、耗材和配件組合的總擁有成本。為此，一些供應商加快了對區域製造的投資，並調整了分銷模式，以降低關稅波動和貨運中斷帶來的風險。

對於醫療服務提供者而言，累積效應體現在採購週期和庫存管理的重新調整。醫院和門診中心與供應商的談判更加嚴格，並評估了配套服務安排，以轉移庫存風險，同時確保能夠獲得先進的體外碎石和內視鏡平台。臨床醫生觀察到，成本壓力影響了設備選擇，促使他們在高階可重複使用系統和價格具有競爭力的單次使用替代方案之間做出選擇，研發重點也轉向了既能保持臨床性能又具有成本效益的設計。同時，資本預算週期也進行了調整，以應對更長的前置作業時間和耗材價格的潛在波動，凸顯了生命週期服務協議和臨床證據對於證明更高初始投資合理性的重要性。

將產品類別、流程差異、終端用戶需求、能量模式、臨床應用和患者群體與購買和臨床偏好聯繫起來的可操作細分洞察

透過產品層面的細分，我們獲得了洞察，揭示了不同設備類別如何影響臨床決策和採購偏好。依產品類型分析，我們發現腎鏡、碎石機及其配件之間有不同的趨勢。諸如取石籃、擴張器器、導絲和導管導引線鞘套等配件屬於高消耗品，對手術效率以及一次性使用與可重複使用的經濟性有顯著影響。對於碎石機平台而言，臨床價值主要體現在碎石效率和維護模式上；而對於腎臟鏡而言，可視化品質和人體工學設計則是關鍵的差異化因素。

手術類型細分顯示，在臨床上適當的情況下，微創手術正逐漸成為主流。微創和超微創手術優先考慮對實質組織的最小干擾，通常需要使用專用的低輪廓器械和精密的取石工具。對於結石負荷較大的患者，微創和標準手術仍然至關重要，需要強大的碎石能力和高效的排放途徑。終端用戶環境的差異正在影響其購買和使用行為。無論是獨立運作的還是醫院附屬的門診手術中心，通常更注重手術量、易於消毒以及耗材消耗的可預測性。

技術細分揭示了能量選擇（雷射、氣動或超音波）如何影響臨床工作流程和資金配置。雷射平台通常需要輔助光纖組件和特定的維護方案；氣動系統為某些類型的結石提供穩健且簡便的解決方案；超音波設備則將碎石與抽吸功能相結合，可在特定臨床情況下加速結石清除。腎結石和鹿角狀結石在應用上的差異導致了不同的手術方案和設備組合，鹿角狀結石病例通常需要多通道策略和聯合能量方法。

最後，成人和兒童患者群體之間的患者類型分類導致了獨特的設備和手術要求：兒科實踐強調小型化器械和手術全期通訊協定，以最大限度地減少對腎實質的影響和麻醉暴露，而成人實踐則包括更廣泛的手術範圍和對合併症管理的考慮，這會影響器械的選擇和輔助技術。

區域觀點下的採用模式、監管差異、製造節點和臨床實務差異，共同驅動全球醫療器材策略。

區域動態對經皮腎結石治療技術的應用和商業化有顯著影響。在美洲，強大的私人醫療機構網路和集中的門診設施正在加速微創技術的應用。經皮，監管路徑和報銷模式持續影響醫院和門診中心之間的資本投資模式和手術流程。該地區的供應鏈節點和本地製造能力也會影響醫療設備和配件的補貨前置作業時間。

由於監管要求和醫療體系資金籌措的差異，歐洲、中東和非洲的能源平台普及速度不一。西歐的醫療中心通常專注於臨床證據、培訓和長期服務關係，而該地區的新興市場則更注重成本效益高的解決方案和可擴展的培訓模式。中東為卓越中心提供了投資機會，而非洲部分地區則面臨基礎設施限制，儘管臨床上有需求，但這些限制阻礙了先進能源平台的普及應用。

在亞太地區，人口結構變化和部分市場手術量激增，推動了對高通量平台和具成本效益耗材的需求。該地區的製造群和供應商生態系統支援產品的快速迭代和具有競爭力的定價模式。同時，臨床實踐模式和醫院基礎設施的多樣性迫使供應商調整其商業化策略，提供模組化系統配置和區域培訓計劃，以確保手術結果的一致性。

競爭與創新的動態變化揭示了現有供應商和新參與企業如何塑造產品開發、服務模式和臨床夥伴關係。

經經皮腎結石治療領域的競爭格局反映了現有設備供應商與靈活參與企業優先考慮模組化設計、服務模式和臨床夥伴關係。主要企業專注於提供整合解決方案，將高性能能量平台與最佳化的器械人體工學設計以及旨在減少停機時間的全面服務協議相結合。新參與企業則傾向於在狹窄的創新方向上競爭，例如一次性設備設計、增強型光纖技術以及簡化的維護要求，以減少門診操作中的摩擦。

整個產業的策略重點包括：透過多機構研究建立可靠的臨床證據；擴大培訓計畫以縮短學習曲線；以及創建能夠協調醫療服務提供者和支付獎勵的商業模式。服務收入和耗材更換率對長期盈利仍然至關重要，這激勵著供應商設計兼顧耐用性和滅菌要求的儀器。製造商與臨床網路之間的夥伴關係日益普遍，從而能夠快速反饋，不斷改進產品，並有助於展現真正的價值提案，從而促進產品的更廣泛應用。

為醫療設備製造商、醫療服務提供者和支付者提供策略建議，以提高腎結石清除手術的普及率、保障淨利率並改善臨床療效。

產業領導者應採取一系列切實可行、基於實證的行動，以增強自身競爭力，同時幫助改善患者預後。首先，應優先開發模組化產品系列，使醫療機構能夠根據手術複雜程度靈活調整設備規模，從而實現與單一供應商建立合作關係，為門診中心和三級醫院提供支援。其次，應投資於臨床證據的收集和實踐培訓夥伴關係，以降低實施風險，並縮短複雜手術（尤其是微型手術）的學習曲線。

第三，透過多元化的採購和區域製造策略最佳化供應鏈韌性，降低關稅波動和物流中斷帶來的風險。第四，設計靈活的商業模式，使供應商的獎勵與設施的吞吐量和品質目標保持一致，例如與結果掛鉤的定價、配套服務協議以及基於訂閱的耗材獲取方式。第五，加速數位化賦能能力的發展，例如程序分析和遠距離診斷，以提高利用率指標並支持基於價值的合約。例如，兒科泌尿系統中心可能會優先考慮低調的兒科專用器械，而三級醫療機構則可能會確保配備強大的碎片化和排放工具，以應對複雜的鹿角狀尿道畸形病例。

採用嚴謹的混合方法研究框架，整合臨床醫師的見解、採購觀點和檢驗的二手證據，以得出可操作的資訊。

調查方法採用定性和定量相結合的研究方法，以獲得對臨床實踐和商業性動態的三角驗證且可重複的視角。主要資料收集工作包括對泌尿系統內視鏡專家、門診手術中心和醫院的採購負責人、生物醫學工程負責人以及醫療器材公司的高級產品經理進行結構化訪談。訪談內容涵蓋了器械效用、維護實際情況、首選能量模式以及手術流程等方面的考量。

二次研究利用同行評審的臨床文獻、監管文件、臨床試驗註冊庫、醫院採購文件和公開的技術規範，檢驗了設備的功能並繪製了其臨床適應症圖譜。資料綜合採用主題編碼來識別臨床和營運方面的優先事項，並包含一個交叉檢驗步驟，將二級資訊來源與訪談結果進行比較，以減少偏差。為確保可比較性，在產品類型、手術類型、最終用戶、技術、應用和患者類型方面均採用了一致的細分邏輯。本研究的局限性包括區域實踐模式的差異以及設備迭代的快速發展，這可能導致短期偏差。儘管如此，本調查方法強調可重複性、透明的資訊來源歸屬以及敏感性分析，以突出共識和爭議領域。

結論是基於臨床發展、商業性壓力以及為確定腎結石治療服務的未來發展方向而進行的合作努力。

經皮腎結石治療處於臨床創新、營運最佳化和政策環境變化的交匯點。器械小型化、能量輸送和可視化技術的進步拓展了手術選擇，使臨床醫生能夠針對成人和兒童患者制定個性化的治療方案，同時應對包括腎結石和複雜鹿角狀結石在內的各種臨床應用。同時，醫療機構對門診治療的偏好以及支付方對醫療價值的重視，正在改變手術的進行地點和方式。

關稅驅動的成本壓力、區域製造業調整以及不斷變化的採購慣例的綜合影響，凸顯了製定適應性強的商業策略和以循證醫學為基礎的產品設計的必要性。醫療服務主導和製造商若能積極合作，共同開展培訓、服務模式和靈活的採購安排，將更有利於在控制成本的同時，維持高品質的醫療服務。展望未來，臨床領導者、供應鏈相關人員和技術開發人員之間的持續合作，對於將創新成果轉化為不同醫療體系中一致且易於獲取的診療路徑至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 門診中心擴大採用小型化經皮腎鏡取石系統
  • 整合先進的影像技術以提高經皮腎鏡取石術的準確性
  • 更重視單步體外碎石術，以縮短手術時間和減少併發症
  • 在經皮腎鏡取石術（PCNL）中，更多地使用超音波引導而非透視引導，以最大限度地減少輻射暴露。
  • 開發機器人經皮經皮腎鏡取石平台以改善手術效果
  • 成本控制措施促使經皮經皮腎結石治療服務擴大。
  • 為因應感染控制和消毒挑戰，對一次性經皮腎鏡取石術（PCNL）配件的需求不斷成長。
  • 擴增實境可視化技術的進步有助於腎切開取石術中精準的腎臟穿刺

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章經皮皮腎結石切除術市場（依產品類型分類）

  • 配件
    • 籃子
    • 擴張器
    • 導管導引線
    • 鞘套
  • 體外碎石機
  • 腎鏡

第9章經皮皮腎結石切除術市場（依手術類型分類）

  • 微
  • 小型的
  • 標準
  • 超迷你

第10章經皮皮腎結石切除術市場（依最終用戶分類）

  • 門診手術中心
    • 獨立中心
    • 醫院附設中心
  • 醫院
    • 私立醫院
    • 公立醫院

第11章經皮皮腎結石切除術市場：依技術分類

  • 雷射
  • 氣動
  • 超音波

第12章經皮皮腎結石清除術市場：依應用領域分類

  • 腎結石
  • 鹿角石

第13章 依病患類型經皮的經皮腎結石切除市場

  • 成人版
  • 孩子們

第14章經皮皮腎結石切除術市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 經經皮腎結石市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國經經皮腎結石市場分析

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Boston Scientific Corporation
    • KARL STORZ SE & Co. KG
    • Olympus Corporation
    • Richard Wolf GmbH
    • Stryker Corporation
    • Cook Medical LLC
    • Teleflex Incorporated
    • CONMED Corporation
    • Dornier MedTech GmbH
    • Lumenis Ltd.
Product Code: MRR-C002B1C99560

The Percutaneous Nephrolithotomy Market is projected to grow by USD 37.07 billion at a CAGR of 8.24% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 19.66 billion
Estimated Year [2025] USD 21.27 billion
Forecast Year [2032] USD 37.07 billion
CAGR (%) 8.24%

An authoritative overview of percutaneous nephrolithotomy that explains contemporary clinical practice, device ecosystems, and procedural variants shaping care delivery

Percutaneous nephrolithotomy is a cornerstone procedure in contemporary urologic practice for the management of complex and sizable renal calculi. Over recent years the procedure has evolved from an exclusively hospital-based intervention into a spectrum of access options characterized by variable instrument footprints, energy modalities, and perioperative pathways. These developments have been driven by parallel advances in device engineering, optics, and energy delivery systems as well as by changing expectations from patients and payers that prioritize shorter stays, faster recovery, and demonstrable safety outcomes.

In this context, clinical teams routinely consider an integrated set of products and procedural choices. Device categories central to the procedure include nephroscopes, lithotripters, and a broad suite of accessories such as baskets, dilators, guidewires, and sheaths. Procedure variants span micro, mini, standard, and ultra-mini approaches, each tailored to stone burden, renal anatomy, and patient comorbidity. End users range from ambulatory surgical centers, both freestanding and hospital affiliated, to private and public hospitals, with technology choices including laser, pneumatic, and ultrasonic modalities. Applications typically distinguish renal calculi from more extensive staghorn presentations, while patient populations differ between adult and pediatric cohorts. Taken together, these elements frame the contemporary clinical pathway and the commercial ecosystem that supports it.

How technological miniaturization, energy diversification, and site-of-care evolution are reshaping clinical routines and commercial strategies in nephrolithotomy

The landscape for percutaneous nephrolithotomy is undergoing several transformative shifts driven by technological, operational, and patient-centered forces. Technological miniaturization and enhancements in endoscopic optics have facilitated less invasive variants of the procedure, prompting clinicians to reconsider traditional size thresholds and perioperative requirements. Concurrently, energy platforms have diversified; laser systems have matured with improved fiber design and energy modulation, pneumatic and ultrasonic options remain important for specific stone compositions, and hybrid approaches have emerged to optimize fragmentation and evacuation.

Operationally, there is a clear movement toward ambulatory and accelerated recovery models. As clinicians and administrators adopt protocols that reduce length of stay without compromising safety, procedure selection and instrument portfolios are re-evaluated. Supply chain resilience and cost-efficiency have also assumed greater importance, encouraging hospitals and ambulatory centers to negotiate service agreements, consider single-use versus reusable trade-offs, and explore strategic sourcing alternatives. Finally, regulatory scrutiny and payer focus on outcomes and value are incentivizing manufacturers to provide robust clinical evidence and to support training programs that accelerate safe adoption of newer techniques and devices.

Assessing the operational and procurement repercussions of US tariff policy changes on device sourcing, manufacturing strategy, and provider purchasing behavior in 2025

Policy decisions influencing tariffs and trade in 2025 have produced material implications across the percutaneous nephrolithotomy supply chain. Manufacturers that rely on cross-border component sourcing have experienced higher landed costs, prompting procurement teams to revisit total cost of ownership calculations for capital equipment, disposables, and accessory portfolios. In response, some suppliers have accelerated regional manufacturing investments and adjusted distribution models to mitigate exposure to fluctuating duties and freight disruptions.

For providers, the cumulative effect has been a recalibration of purchasing cadence and inventory management. Hospitals and ambulatory centers have engaged in more rigorous vendor negotiations and have evaluated bundled service arrangements that shift inventory risk while preserving access to advanced lithotripsy and endoscopic platforms. Clinicians have observed impacts on device selection, as cost pressures can influence the choice between high-end reusable systems and competitively priced single-use alternatives, while research and development prioritization has leaned toward cost-efficient designs that retain clinical performance. In parallel, capital budgeting cycles have been adjusted to account for longer lead times and potential variability in consumable pricing, thereby reinforcing the importance of lifecycle service agreements and clinical evidence that justify higher initial investment.

Practical segmentation insights that link product classes, procedural variants, end user needs, energy modalities, clinical applications, and patient cohorts to purchasing and clinical preferences

Insights derived from product-level segmentation clarify how different device classes interact with clinical decisions and procurement preferences. The analysis of product type indicates distinct dynamics among nephroscopes, lithotripters, and accessories. Accessories such as baskets, dilators, guidewires, and sheaths function as high-volume consumables with important implications for procedure efficiency and single-use versus reusable economics. Lithotripter platforms concentrate clinical value in fragmentation efficiency and maintenance models, while nephroscopes implicate visualization quality and ergonomics as primary differentiators.

Procedure type segmentation highlights a progressive shift toward less invasive methods where clinically appropriate. Micro and ultra-mini approaches prioritize minimal parenchymal disruption and often require specialized, lower-profile instruments and refined stone extraction tools. Mini and standard procedures remain essential for larger stone burdens, demanding robust fragmentation capability and efficient evacuation pathways. Differences in end user environment shape purchasing and utilization behaviors. Ambulatory surgical centers, whether freestanding or hospital based, tend to emphasize throughput, ease of sterilization, and predictable consumable consumption, whereas private and public hospitals manage broader case complexity and typically maintain more diverse capital inventories.

Technology segmentation underscores how energy modality selection-laser, pneumatic, or ultrasonic-affects clinical workflows and capital allocation. Laser platforms often require ancillary fiber sets and specific maintenance frameworks, pneumatic systems offer rugged simplicity for certain stone types, and ultrasonic devices combine fragmentation with suction capabilities that can accelerate clearance for specific clinical scenarios. Application-based distinctions between renal calculi and staghorn calculi translate into different procedural planning and device combinations, with staghorn cases necessitating multi-tract strategies and often composite energy approaches.

Finally, patient type segmentation between adult and pediatric cohorts drives unique device and procedural requirements. Pediatric practice emphasizes miniaturized instruments and tailored perioperative protocols to minimize renal parenchymal impact and anesthesia exposure, whereas adult care encompasses a broader procedural repertoire and comorbidity management considerations that influence device selection and adjunctive technologies.

A region-by-region perspective on adoption patterns, regulatory variability, manufacturing nodes, and clinical practice differences driving device strategies globally

Regional dynamics exert a pronounced influence on how percutaneous nephrolithotomy technologies are adopted and commercialized. In the Americas, robust private-provider networks and a high concentration of ambulatory facilities have accelerated uptake of minimally invasive techniques, while regulatory pathways and reimbursement models continue to shape capital investment patterns and procedure routing between hospitals and outpatient centers. Supply chain nodes and local manufacturing capabilities in the region also influence lead times for capital equipment and accessory replenishment.

Across Europe, the Middle East, and Africa, heterogeneity in regulatory requirements and health system financing produces a patchwork of adoption speeds. Western European centers often emphasize clinical evidence, training, and long-term service relationships, whereas emerging markets within the broader region prioritize cost-effective solutions and scalable training models. The Middle East presents opportunities for centers of excellence investment, and parts of Africa contend with infrastructure limitations that constrain the adoption of advanced energy platforms despite clinical need.

In the Asia-Pacific region, demographic trends and high procedure volumes in select markets drive demand for both high-throughput platforms and cost-efficient consumables. Regional manufacturing clusters and supplier ecosystems support rapid product iteration and competitive pricing models. At the same time, variations in clinical practice patterns and hospital infrastructure require suppliers to adapt their commercialization strategies, offering modular system configurations and localized training initiatives to ensure consistent procedural outcomes.

Competitive and innovation dynamics revealing how established suppliers and nimble entrants are shaping product development, service models, and clinical partnerships

Competitive dynamics in the percutaneous nephrolithotomy space reflect a balance between established device providers and agile entrants that prioritize modularity, service models, and clinical partnerships. Leading companies focus on integrated solution sets that combine high-performance energy platforms with optimized instrument ergonomics and comprehensive service agreements designed to reduce downtime. Newer entrants often compete on narrow innovation vectors such as single-use instrument design, enhanced fiber technology, or simplified maintenance requirements that lower the operational friction for ambulatory settings.

Across the industry, strategic priorities include building robust clinical evidence through multicenter collaborations, expanding training programs that shorten the learning curve, and structuring commercial models that align incentives across providers and payers. Service revenue streams and consumable replacement rates remain important to long-term profitability, encouraging suppliers to design instruments that balance durability with sterilization demands. Partnerships between manufacturers and clinical networks are increasingly prevalent, enabling rapid feedback loops for iterative product improvements and helping to demonstrate real-world value propositions that support broader adoption.

Actionable strategic recommendations for device manufacturers, providers, and payers to accelerate adoption, protect margins, and improve clinical outcomes in nephrolithotomy

Industry leaders should pursue a set of pragmatic, evidence-driven actions to strengthen competitive positioning while supporting improved patient outcomes. First, prioritize development of modular product families that allow providers to scale instrument footprints to procedural complexity, enabling a single vendor relationship to support both ambulatory centers and tertiary hospitals. Second, invest in clinical evidence generation and hands-on training partnerships that reduce adoption risk and shorten the learning curve for advanced techniques, particularly for miniaturized procedures.

Third, optimize supply chain resilience through diversified sourcing and regional manufacturing strategies that reduce exposure to tariff volatility and logistic disruptions. Fourth, design flexible commercial models-such as outcome-linked pricing, bundled service agreements, and subscription-based access to consumables-that align vendor incentives with institutional goals for throughput and quality. Fifth, accelerate digital-enablement features, including procedure analytics and remote diagnostics for capital equipment, to improve utilization metrics and support value-based contracting. Finally, tailor product design for distinct patient cohorts and settings; for example, prioritize low-profile, pediatric-specific instruments for pediatric urology centers while ensuring robust fragmentation and evacuation tools for complex staghorn cases in tertiary facilities.

A rigorous, mixed-methods research framework that integrates clinician insights, procurement perspectives, and validated secondary evidence to produce actionable intelligence

The research approach combined qualitative and quantitative methods to ensure a triangulated, reproducible view of clinical practice and commercial dynamics. Primary data collection involved structured interviews with practicing endourologists, procurement leaders from ambulatory surgical centers and hospitals, biomedical engineering personnel, and senior product managers across device firms. These conversations explored device utility, maintenance realities, preferred energy modalities, and procedural workflow considerations.

Secondary research drew on peer-reviewed clinical literature, regulatory filings, clinical trial registries, hospital procurement documents, and publicly available technical specifications to validate device capabilities and to map clinical indications. Data synthesis employed thematic coding to identify recurring clinical and operational priorities, while cross-validation steps compared interview findings with secondary source signals to reduce bias. Segmentation logic was applied consistently across product type, procedure type, end user, technology, application, and patient type to ensure comparability. Limitations include variability in regional practice patterns and the rapid pace of device iteration that may introduce short-term divergence; nevertheless, the methodology emphasizes reproducibility, transparent source attribution, and sensitivity analyses to highlight areas of consensus and contention.

Concluding synthesis of clinical evolution, commercial pressures, and collaborative imperatives that will determine future trajectories for nephrolithotomy care delivery

Percutaneous nephrolithotomy stands at the intersection of clinical innovation, operational optimization, and shifting policy landscapes. Advances in device miniaturization, energy delivery, and visualization have expanded procedural options, enabling clinicians to tailor approaches across adult and pediatric populations while accommodating varied clinical applications such as renal calculi and complex staghorn disease. Simultaneously, provider preference for ambulatory pathways and payer emphasis on value are reshaping where and how procedures are performed.

The combined effects of tariff-driven cost pressures, regional manufacturing adjustments, and evolving procurement practices underscore the need for adaptable commercial strategies and evidence-backed product design. Providers and manufacturers that proactively align on training, service models, and flexible purchasing arrangements will be best positioned to sustain quality outcomes while managing cost imperatives. Looking forward, sustained collaboration between clinical leaders, supply chain stakeholders, and technology developers will be essential to translate innovation into consistent, accessible care pathways across diverse health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of miniaturized percutaneous nephrolithotomy systems in ambulatory centers
  • 5.2. Integration of advanced imaging technologies to enhance percutaneous nephrolithotomy precision
  • 5.3. Growing focus on single-step stone fragmentation devices to reduce procedure times and complications
  • 5.4. Increasing utilization of ultrasound guidance over fluoroscopy to minimize radiation exposure in PCNL
  • 5.5. Development of robotic-assisted percutaneous nephrolithotomy platforms for improved surgical outcomes
  • 5.6. Expansion of outpatient percutaneous nephrolithotomy services driven by cost containment initiatives
  • 5.7. Rising demand for disposable PCNL accessories to address infection control and sterilization challenges
  • 5.8. Advancements in augmented reality visualization aiding precise renal access during nephrolithotomy procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Nephrolithotomy Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Baskets
    • 8.1.2. Dilators
    • 8.1.3. Guidewires
    • 8.1.4. Sheaths
  • 8.2. Lithotripters
  • 8.3. Nephroscopes

9. Percutaneous Nephrolithotomy Market, by Procedure Type

  • 9.1. Micro
  • 9.2. Mini
  • 9.3. Standard
  • 9.4. Ultra Mini

10. Percutaneous Nephrolithotomy Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding Centers
    • 10.1.2. Hospital Based Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals

11. Percutaneous Nephrolithotomy Market, by Technology

  • 11.1. Laser
  • 11.2. Pneumatic
  • 11.3. Ultrasonic

12. Percutaneous Nephrolithotomy Market, by Application

  • 12.1. Renal Calculi
  • 12.2. Staghorn Calculi

13. Percutaneous Nephrolithotomy Market, by Patient Type

  • 13.1. Adult
  • 13.2. Pediatric

14. Percutaneous Nephrolithotomy Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Percutaneous Nephrolithotomy Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Percutaneous Nephrolithotomy Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Boston Scientific Corporation
    • 17.3.2. KARL STORZ SE & Co. KG
    • 17.3.3. Olympus Corporation
    • 17.3.4. Richard Wolf GmbH
    • 17.3.5. Stryker Corporation
    • 17.3.6. Cook Medical LLC
    • 17.3.7. Teleflex Incorporated
    • 17.3.8. CONMED Corporation
    • 17.3.9. Dornier MedTech GmbH
    • 17.3.10. Lumenis Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PERCUTANEOUS NEPHROLITHOTOMY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PERCUTANEOUS NEPHROLITHOTOMY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PERCUTANEOUS NEPHROLITHOTOMY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY DILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SHEATHS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MICRO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY MINI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STANDARD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRA MINI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY LASER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PNEUMATIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY STAGHORN CALCULI, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 294. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA PERCUTANEOUS NEPHROLITHOTOMY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION